The Role of Corticosteroids in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Novak, Barbara
October 2002
Critical Care Nurse;Oct2002, Vol. 22 Issue 5, p80
Academic Journal
Presents information on a study that demonstrated that an 8-week course of steroids was just as effective as a 2-week course for chronic obstructive pulmonary disease (COPD) exacerbation treatment. Factors associated with the hospitalizations for COPD exacerbations; Drugs in the treatment of COPD exacerbations; Treatment for COPD exacerbations recommended by the Global Initiative for Chronic Obstructive Lung Diseases.


Related Articles

  • Do systemic corticosteroids lessen symptoms in acute exacerbations of COPD?  // Journal of Family Practice;Dec2003, Vol. 52 Issue 12, p979 

    Systemic corticosteroids improve measures of dyspnea in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD). The optimal dose of systemic corticosteroids to achieve these benefits is uncertain. An international consensus panel recommended 30 to 40 mg of oral...

  • Chronic Obstructive Pulmonary Disease: Emerging Trends in Pharmacotherapy. Restrepo, Ruben D.; Hanania, Nicola A. // Current Medical Literature: Respiratory Medicine;2009, Vol. 23 Issue 2, p29 

    The article reviews emerging therapies for the treatment of stable chronic obstructive pulmonary disease (COPD). The two categories of inhaled agents for the management of stable COPD are bronchodilators and corticosteroids. It explains in detail the use of novel biological targets like novel...

  • Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Is There a Clinical Benefit? Man, S. F. Paul; Sin, Don D. // Drugs;2005, Vol. 65 Issue 5, p579 

    Chronic obstructive pulmonary disease (COPD) is a serious illness that affects over 5% of the adult population. It is one of the few conditions for which the mortality and morbidity are still increasing. Experts expect COPD to become the third leading cause of death and the fifth leading cause...

  • Análise da Revisão Cochrane: Uso de Corticoterapia Sistémica nas Exacerbações Agudas da Doença Pulmonar Obstrutiva Crónica. Cochrane Database Syst Rev. 2014, 9:CD001288. AZEVEDO, Pedro; COSTA, João; VAZ-CARNEIRO, António // Acta Medica Portuguesa;set/out2014, Vol. 27 Issue 5, p537 

    Acute exacerbations of chronic obstructive pulmonary disease are a major cause of hospital admissions and mortality, contributing to the decline in lung function, exercise capacity and quality of life. Infections are the major cause of exacerbations and treatment includes antibiotics,...

  • Inhaled Corticosteroids: Why Do Physicians and Patients Fail to Comply With Guidelines for Managing Asthma? Reed, Charles E. // Mayo Clinic Proceedings;Apr2004, Vol. 79 Issue 4, p453 

    Points out that failure of physicians to prescribe inhaled corticosteroids for patients with persistent, even mild persistent, asthma has a major adverse impact on the quality of life and healthcare costs. Reasons why physicians do not prescribed inhaled corticosteroids; Disagreement of...

  • Corticosteroids for exacerbations of COPD. Elliott, William T. // Neurology Alert;Aug2010 Pharmacology, p2 

    The article presents a study published in the "Journal of the American Medical Association" which showed that lower doses of corticosteroids taken orally are as effective as higher doses of IV steroids in the treatment of acute exacerbation of chronic obstructive pulmonary disease (ae-COPD).

  • SHORT CUTS. Tonks, Alison // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;2/21/2009, p438 

    No abstract available.

  • COPD combination therapy questioned.  // Independent Nurse;11/2/2009, p15 

    The article discusses a Dutch study concerning the addition of long-acting beta-agonists (LABAs) to corticosteroid therapy for chronic obstructive pulmonary disease (COPD). The findings of the study negate an analysis of the Toxoplasmosis, Rubella, Cytomegalovirus and Herpes Simplex (TORCH)...

  • Researchers Discover Why Steroid Treatment for COPD Is Ineffective.  // Biomedical Market Newsletter;10/24/2011, Vol. 21, p382 

    The article reports on the findings of researchers on inefficacy of steroid treatment for chronic obstructive pulmonary disease (COPD). Researchers at the Johns Hopkins Bloomberg School of Public Health have revealed that corticosteroids do not improve survival nor alter the progression of COPD....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics